Marvel Biosciences Price To Book vs. Return On Equity

MRVL Stock   0.14  0.02  12.50%   
Based on Marvel Biosciences' profitability indicators, Marvel Biosciences Corp may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Marvel Biosciences' ability to earn profits and add value for shareholders. At this time, Marvel Biosciences' ROIC is fairly stable compared to the past year. Days Payables Outstanding is likely to climb to 469.65 in 2024, despite the fact that Book Value Per Share is likely to grow to (0.05).
For Marvel Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Marvel Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Marvel Biosciences Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Marvel Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Marvel Biosciences Corp over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Marvel Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marvel Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marvel Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Marvel Biosciences Corp Return On Equity vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Marvel Biosciences's current stock value. Our valuation model uses many indicators to compare Marvel Biosciences value to that of its competitors to determine the firm's financial worth.
Marvel Biosciences Corp is considered to be number one stock in price to book category among its peers. It is rated below average in return on equity category among its peers . At this time, Marvel Biosciences' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marvel Biosciences' earnings, one of the primary drivers of an investment's value.

Marvel Return On Equity vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Marvel Biosciences

P/B

 = 

MV Per Share

BV Per Share

 = 
226.82 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Marvel Biosciences

Return On Equity

 = 

Net Income

Total Equity

 = 
-3.8
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Marvel Return On Equity Comparison

Marvel Biosciences is currently under evaluation in return on equity category among its peers.

Marvel Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Marvel Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Marvel Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Marvel Biosciences' change in net profit over the period of time. It can combine multiple indicators of Marvel Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Loss-2.3 M-2.4 M
Net Interest Income-34.6 K-32.9 K
Operating Income-2 M-2.1 M
Net Loss-2.1 M-2.2 M
Income Before Tax-2.1 M-2.2 M
Total Other Income Expense Net-5.5 K-5.8 K
Net Loss-2.1 M-2.2 M
Income Tax Expense-136.6 K-143.5 K
Change To Netincome2.1 M2.2 M
Net Loss(0.05)(0.05)
Income Quality 0.52  0.46 

Marvel Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Marvel Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Marvel Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Marvel Biosciences' important profitability drivers and their relationship over time.

Use Marvel Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Marvel Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marvel Biosciences will appreciate offsetting losses from the drop in the long position's value.

Marvel Biosciences Pair Trading

Marvel Biosciences Corp Pair Trading Analysis

The ability to find closely correlated positions to Marvel Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Marvel Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Marvel Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Marvel Biosciences Corp to buy it.
The correlation of Marvel Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Marvel Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Marvel Biosciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Marvel Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Marvel Biosciences position

In addition to having Marvel Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run FinTech Thematic Idea Now

FinTech
FinTech Theme
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Marvel Stock Analysis

When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.